中文产业新闻精选评分70Chinese source
FDA 批准默沙东/卫材贝组替凡联合仑伐替尼用于既往接受 PD-1/PD-L1 抑制剂治疗的晚期透明细胞肾细胞癌
全球首个！默沙东/卫材肾癌联合疗法获批
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
全球首个！默沙东/卫材肾癌联合疗法获批
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.